AstraZeneca PLC (OTCMKTS:AZNCF) Announces Dividend of $2.10

AstraZeneca PLC (OTCMKTS:AZNCF) declared a dividend on Thursday, February 6th,NASDAQ Dividends reports. Stockholders of record on Friday, February 21st will be paid a dividend of 2.10 per share on Monday, March 24th. The ex-dividend date is Wednesday, February 19th. This is an increase from AstraZeneca’s previous dividend of $1.00.

AstraZeneca Price Performance

AZNCF stock traded up $16.83 during trading on Thursday, reaching $151.50. 922 shares of the company traded hands, compared to its average volume of 2,700. The business has a 50 day simple moving average of $134.05 and a 200 day simple moving average of $146.53. AstraZeneca has a 12 month low of $118.16 and a 12 month high of $175.00.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.